PERTH, Australia – Australia is launching an online "innovation showcase" that aims to catalogue and track the progress of innovations in the pharmaceutical, medical technology and digital health space across Australia in real time on a public platform open to investors, health practitioners and the public.
PERTH, Australia – Australian stem cell therapy company Mesoblast Ltd. said its allogeneic mesenchymal stem cell candidate, MSC-100-IV (remestemcel-L), met the primary endpoint in a phase III trial in children with refractory acute graft-vs.-host disease (aGVHD).
PERTH, Australia – Australian stem cell therapy company Mesoblast Ltd. said its allogeneic mesenchymal stem cell candidate, MSC-100-IV (remestemcel-L), met the primary endpoint in a phase III trial in children with refractory acute graft-vs.-host disease (aGVHD).
PERTH, Australia – In 2017, Australia's Therapeutic Goods Administration (TGA) approved the lowest number of new molecular entities since 2012 – just 34, compared to 42 in 2016 and 45 in 2015.
PERTH, Australia – Allergan plc is acquiring Sydney-based Elastagen Pty Ltd., a private company with a tissue repair platform that complements Allergan's aesthetic and dermatology franchise.
